Quick / INR

The Quick/INR test, also known as Prothrombin Time (PT) or International Normalized Ratio (INR), is a blood test that measures how long it takes blood to clot. It specifically evaluates the extrinsic pathway of coagulation, primarily assessing the function of clotting factors I (fibrinogen), II (prothrombin), V, VII, and X. Researchers found that this test is crucial for monitoring anticoagulant therapy, particularly with vitamin K antagonists like warfarin, as it helps standardize results across different laboratories by using the INR calculation. Clinically, Quick/INR is significant in diagnosing and managing bleeding disorders, liver disease, and vitamin K deficiency. Elevated PT/INR values may indicate a risk of bleeding, while lower values suggest a potential for thrombosis. In the context of athletic performance, biohacking, or longevity, maintaining an optimal INR is crucial for preventing both excessive bleeding and clot formation, which can impact overall health and recovery. However, researchers observed that factors such as diet, medication, and liver function can confound test results. Time of day and fasting status generally do not affect the Quick/INR, but consistent testing conditions are recommended for accurate monitoring. Interfering factors include recent changes in diet, especially vitamin K intake, and certain medications that affect coagulation pathways.